Eisai Inc.

In August 2022, Eisai Inc. cut the ribbon on a 15-story, 332,800-square-foot space that serves as the hub for the company, which is the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co. Ltd.
Feb 28, 2025

More layoffs coming to NJ’s pharma sector

Along with Nutley-based Eisai, several other New Jersey-based giants in the space have conducted layoffs over the past few months, including Bristol Myers Squibb, Bayer and Johnson & Johnson. 

In August 2022, Eisai Inc. cut the ribbon on a 15-story, 332,800-square-foot space that serves as the hub for the company, which is the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co. Ltd.
Jul 7, 2023

Alzheimer’s drug Leqembi receives full FDA approval

The breakthrough treatment from Eisai and Biogen is the first and only approved to show reduced rates of disease progression and to slow cognitive and functional decline in adults with the disease.

In August 2022, Eisai Inc. cut the ribbon on a 15-story, 332,800-square-foot space that serves as the hub for the company, which is the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co. Ltd.
Jun 12, 2023

FDA panel unanimously endorses Eisai, Biogen Alzheimer’s drug

The medicine will be used to help early-stage patients with mild cognitive impairment or the mild dementia stage of the debilitating neurodegenerative disease that affects more than 6.5 million Americans.

Eisai Inc. HQ
Jan 9, 2023

Eisai’s Alzheimer’s drug receives FDA approval

The medicine is among a new category that works by targeting the root of the disease to reduce sticky clumps of toxic proteins in the brain.

Dec 8, 2022

Inside Eisai: SJP completes 300K-square-foot buildout at Nutley HQ (slideshow)

Take a look at the new space, which is home to the pharmaceutical company's approximately 1,200 corporate and R&D employees.

Eisai Inc. HQ
Nov 7, 2022

Eisai charts next chapter at iconic site in Nutley

In August, Eisai Inc. cut the ribbon on a 15-story, 332,800-square-foot space that serves as its hub. NJBIZ recently took a tour of this new state-of-the-art center in Nutley.

Eisai US hhceco Center in Nutley
Aug 18, 2022

Eisai cuts ribbon on new US headquarters in Nutley

According to Chairman and CEO Ivan Cheung, the 15-story, 332,800-square-foot space facility at the ON3 Campus, "reinforces our 30-year commitment to New Jersey and signifies the beginning of a new chapter as we establish an ecosystem platform to collaborate with industry, government, medical organizations and the community to deliver breakthrough medicines and new solutions that alleviate the heal[...]

clinical research
Jan 25, 2022

Eisai appoints VP of gov’t affairs and policy

Tricia Brooks will be responsible for guiding, representing and growing the company's work to create a network of bipartisan relationships with key decision makers.